Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Bioengineering & Translational Medicine|November 17, 2025
Near Infrared-light responsive chlorin e6 pro-drug micellar photodynamic therapy for oral cancerMilan Paul, Swati Biswas
International Journal of Biological Macromolecules|November 22, 2023
Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancerMilan Paul, Balaram Ghosh, Swati Biswas
Drug Delivery and Translational Research|May 16, 2024
F127/chlorin e6-nanomicelles to enhance Ce6 solubility and PDT-efficacy mitigating lung metastasis in melanomaMilan Paul, Balaram Ghosh, Swati Biswas
Nanomedicine (London, England)|July 2, 2024
Tocopherol-human serum albumin nanoparticles enhance lapatinib delivery and overcome doxorubicin resistance in breast cancerMilan Paul, Sneha Das, Balaram Ghosh, et al.
Expert Opinion on Drug Delivery|October 18, 2022
Current trends in the use of human serum albumin for drug delivery in cancerMilan Paul, Asif Mohd Itoo, Balaram Ghosh, et al.
Carbohydrate Polymers|February 6, 2022
Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancerAsif Mohd Itoo, Milan Paul, Balaram Ghosh, et al.
Journal of Photochemistry and Photobiology. B, Biology|December 16, 2022
Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinomaMilan Paul, Asif Mohd Itoo, Balaram Ghosh, et al.
Biomaterials Advances|July 12, 2023
Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancerAsif Mohd Itoo, Milan Paul, Balaram Ghosh, et al.
International Journal of Pharmaceutics|January 18, 2022
Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanomaSoniya Kumbham, Milan Paul, Asif Itoo, et al.
Scientific Reports|December 29, 2024
Self-propelling, protein-bound magnetic nanobots for efficient in vitro drug delivery in triple negative breast cancer cellsNeha Naikwadi, Milan Paul, Swati Biswas, et al.
Pageof 5